- UroToday Home
- Urologic Oncology
Prostate Cancer Abstracts and Beyond
Recent Abstracts
-
SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trial.Prostate CancerJuly 1, 2026
-
Topographical and stage-related expression of nectin-4 in prostate cancer.Prostate CancerJuly 1, 2026
-
Case of Basal Cell Prostate Cancer and Recurrence With Prostatic Adenocarcinoma in a United States Military Veteran Exposed to Agent Orange.Prostate CancerJuly 1, 2026
-
Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicine.Prostate CancerJuly 1, 2026
-
18F-Fluciclovine or 68Ga-PSMA-11 PET/CT-guided Salvage Radiotherapy Changes in Postprostatectomy Biochemical Recurrence: Secondary Analysis of the EMPIRE-2 Trial.Prostate CancerJuly 1, 2026
-
Long-term trends in the burden of prostate cancer in the United States from 1990 to 2021: A detailed analysis based on the Global Burden of Disease Study 2021.Prostate CancerJune 30, 2026
-
Deep learning classification of significant prostate cancer on MRI: a systematic review and meta-analysis.Prostate CancerJune 30, 2026
-
Radioligand Therapy for Prostate Cancer - A Clinical Consultation Guide.Prostate CancerJune 30, 2026
-
Cancer-specific mortality of grade group 1 prostate cancer: Results from Surveillance, Epidemiology, and End Results Database, 2004-2021.Prostate CancerJune 30, 2026
-
Efficacy and Safety Differences Between Abiraterone and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-analysis of Real-World Studies.Prostate CancerJune 30, 2026
Beyond the Abstracts
-
Quantifying the Renal Impact of [177Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN Registry - Beyond the AbstractProstate CancerJune 25, 2026
-
PANDA-PLUS: Improved Dataset of Prostate Whole Slide Images from PANDA Challenge with Pixel-Level Expert Annotations - Beyond the AbstractProstate CancerJune 25, 2026
-
NeuroSAFE-Guided Robot-Assisted Radical Prostatectomy versus Standard RARP: Systematic Review and Meta-Analysis of Comparative Studies - Beyond the AbstractProstate CancerJune 23, 2026
-
Prostate Cancer Mortality Among Men with and Without Comorbidity: Long-Term Results from the European Randomized Study of Screening for Prostate Cancer Rotterdam - Beyond the AbstractProstate CancerJune 18, 2026
-
Risk-Adapted Follow-up after Negative MRI-Targeted Biopsy in PI-RADS 3-5 Lesions: A Clinical Cohort Study with Diagnostic Stewardship Modeling - Beyond the AbstractProstate CancerJune 15, 2026
-
Testosterone-Sparing Treatment Strategies for Biochemically Recurrent Prostate Cancer After Radical Prostatectomy - Beyond the AbstractProstate CancerJune 15, 2026
-
LuRa: Efficacy and Safety of Radium-223 Following [177Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer - Beyond the AbstractProstate CancerJune 12, 2026
-
Real-World Effectiveness and Treatment Persistence of Darolutamide, Apalutamide, and Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter Study - Beyond the AbstractProstate CancerJune 12, 2026
-
Neoadjuvant Fc-Enhanced Anti-CTLA-4 Targets Tregs to Augment Androgen Deprivation in High-Risk Prostate Cancer: A Randomized Phase I Trial - Beyond the AbstractProstate CancerJune 9, 2026
-
Aglatimagene Besadenovec (CAN-2409) with Radiotherapy for Patients with Localised Prostate Cancer: A Phase 3, Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial - Beyond the AbstractProstate CancerJune 8, 2026